US 8058271
Selective inhibitors of rock protein kinase and uses thereof
granted A61PA61P1/04A61P11/06
Quick answer
US patent 8058271 (Selective inhibitors of rock protein kinase and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/04, A61P11/06, A61P13/12, A61P15/06